Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink

Fig. 1

A Schematic illustration of the workflow of this study. Created with Biorender.com. B Schematic presentation of the hPSC-CEnC differentiation for bioprinting. LN521 Human recombinant laminin 521, FIBRIN Fibrin membrane, E8 Flex Essential 8 Flex Medium, SB Activin/BMP/TGF-β pathway inhibitor SB431542, CHIR GSK-3 inhibitor and WNT pathway activator CHIR99021, RA Retinoic acid, ROCK ROCK inhibitor Y27632

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512